Related Experiment Videos
Endoscopic retrograde hemorrhoidal sclerotherapy using 23.4% saline: a preliminary report
J L Ponsky1, J D Mellinger, I B Simon
1Department of Surgery, Mt. Sinai Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106.
Gastrointestinal Endoscopy
|March 1, 1991
Summary
This study found that 23.4% saline injection sclerotherapy is an effective and safe treatment for symptomatic internal hemorrhoids, relieving bleeding and prolapse with high patient satisfaction.
Area of Science:
- Gastroenterology
- Colorectal Surgery
Background:
- Injection sclerotherapy is a historical treatment for symptomatic hemorrhoids.
- Concerns regarding sclerosant-related morbidity and anoscopic techniques have limited its use in the US.
Purpose of the Study:
- To evaluate the efficacy and safety of 23.4% saline as a nonallergenic sclerosant for flexible endoscopic treatment of internal hemorrhoids.
Main Methods:
- An initial evaluation was conducted on 19 patients with symptomatic grade I, II, or III internal hemorrhoids.
- 23.4% saline was used as the sclerosant in a flexible endoscopic approach.
Main Results:
- The technique was highly effective in relieving bleeding associated with hemorrhoids.
- Prolapse symptoms were frequently alleviated.
- The procedure was well-tolerated, with high patient satisfaction and low complication rates, including no serious adverse events.
Conclusions:
- 23.4% saline injection sclerotherapy is a safe and effective modality for treating symptomatic internal hemorrhoids.
- It is suitable for single-session endoscopic evaluation and therapy, particularly for patients with lower gastrointestinal bleeding due to hemorrhoidal disease.